Trademark: 79233960
Word
REVLANTE
Status
Registered
Status Code
700
Status Date
Tuesday, November 10, 2020
Serial Number
79233960
Registration Number
6191892
Registration Date
Tuesday, November 10, 2020
Mark Type
4000
Filing Date
Saturday, March 24, 2018
Published for Opposition
Tuesday, August 25, 2020

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Mar 21, 2023
Final Decision Transaction Processed By Ib
Dec 28, 2022
Final Decision Processed And Sent To Ib
Nov 10, 2020
Registered-Principal Register
Aug 25, 2020
Published For Opposition
Aug 5, 2020
Notification Of Possible Opposition Sent To Ib
Aug 5, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 5, 2020
Notice Of Publication
Jul 21, 2020
Electronic Record Review Complete
Jul 21, 2020
Attorney Review Completed
Jul 16, 2020
Correction From Ib Entered - Attorney Review Required
Jul 3, 2020
On Hold - Electronic Record Review Required
May 27, 2020
Reg. Cancelled - Restored To Pendency
May 27, 2020
Assigned To Petition Staff
May 26, 2020
Request To Cancel Inadvertently Issued Registration Received
Mar 1, 2019
Notification Processed By Ib
Jan 16, 2019
Final Disposition Notice Sent To Ib
Jan 16, 2019
Final Disposition Processed
Jan 3, 2019
Grant Of Protection Created, To Be Sent To Ib
Dec 20, 2018
Correction Transaction Received From Ib
Dec 4, 2018
Registered-Principal Register
Nov 2, 2018
Notification Processed By Ib
Sep 18, 2018
Published For Opposition
Sep 5, 2018
Notification Of Possible Opposition Sent To Ib
Sep 5, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 29, 2018
Notice Of Publication
Jul 5, 2018
Withdrawn From Pub - Og Review Query
Jul 4, 2018
Notice Of Publication
Jun 19, 2018
Approved For Pub - Principal Register
Jun 19, 2018
Assigned To Examiner
Jun 16, 2018
Application Filing Receipt Mailed
Jun 12, 2018
New Application Office Supplied Data Entered
Jun 11, 2018
Limitation From Original Application Entered
Jun 7, 2018
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24